Boston is an active market for healthcare M&A, with deal flow across physician practices, home health, behavioral health, specialty pharmacy, and health IT. This list covers 12 active healthcare M&A advisors in 2026 - deal sizes, sector focus, and verified recent transactions.
Boston healthcare M&A in 2026
US healthcare M&A deal value reached $46 billion in 2025, with Q4 rebounding strongly as buyers sought scale and AI-enabled health technology. Healthcare deal volume is projected to increase 10-15% in 2026, with physician consolidation, behavioral health platforms, and home infusion among the most active sub-sectors.
Boston's healthcare M&A market is driven by Massachusetts-specific dynamics: large payer systems like Blue Cross Blue Shield MA create unique payor negotiation leverage for healthcare services businesses. Mass General Brigham and other Boston hospital systems are active acquirers of physician practices.
Set up an Ellty data room before your first advisor conversation. Healthcare buyers check HIPAA compliance documentation, payor mix, and physician employment agreements before sending an LOI.
Ellty's access control features let you stage which buyers access patient data agreements and compliance records. Protect sensitive HIPAA documentation until buyers have signed confidentiality agreements.
What separates Boston healthcare M&A advisors
Provident Healthcare Partners is the Boston-headquartered first call for middle-market healthcare services M&A, with 28 years in the market and a verified four-deal track record in 2025. They received the Healthcare Investment Bank of the Year award at the 13th Annual America's M&A Atlas Awards.
Outcome Capital covers medical devices, diagnostics, and life science services from their Boston office and uses a strategy-led execution model with senior MD engagement throughout. In February 2025, Outcome Capital advised RealizedCare on its sale to XRHealth.
Massachusetts healthcare M&A has unique regulatory considerations - the Massachusetts Attorney General has broad oversight of healthcare consolidation, requiring notification for certain transactions. Boston advisors who understand Massachusetts healthcare regulatory dynamics can navigate this process without surprises.
| Advisor | Deal Type | Deal Size | Sector Focus | Website | |
|---|---|---|---|---|---|
| Provident Healthcare Partners | Provident Healthcare Partners | Both | $20M-$300M | Physician practices, home health, specialty pharmacy, infusion, behavioral health, dental | providenthp.com |
| Outcome Capital | Outcome Capital | Both | $10M-$150M | Medical devices, diagnostics, life-science services, digital health, biotech | outcomecapital.com |
| Houlihan Lokey (Healthcare) | Houlihan Lokey | Both | $50M-$5B+ | Physician services, behavioral health, retail health, health IT, medical products | hl.com |
| Harris Williams (Healthcare) | Harris Williams | Both | $50M-$2B+ | Healthcare & life sciences, health IT, medical products, value-based care | harriswilliams.com |
| William Blair (Healthcare) | William Blair | Both | $50M-$2B+ | Healthcare services, health IT, medical technology, pharma outsourcing | williamblair.com |
| Lincoln International (Healthcare) | Lincoln International | Both | $50M-$1B+ | Healthcare services, life sciences, pharma outsourcing, medtech, health IT | lincolninternational.com |
| Piper Sandler (Healthcare) | Piper Sandler | Both | $50M-$2B+ | Healthcare services, health IT, pharma, biotech, medical devices | pipersandler.com |
| Jefferies (Healthcare) | Jefferies | Both | $100M-$5B+ | Pharma, biotech, medical devices, healthcare services, health IT | jefferies.com |
| Raymond James (Healthcare) | Raymond James | Both | $25M-$1B+ | Healthcare services, physician groups, home health, specialty pharma | raymondjames.com |
| M&A Healthcare Advisors | M&A Healthcare Advisors | Sell-side | $5M-$100M | Lower-middle market healthcare services, pharmacy, home health, physician practices | mahealthcareadvisors.com |
| FOCUS Investment Banking | FOCUS Investment Banking | Both | $5M-$250M | Healthcare services, health IT, diagnostics, provider services, pharmacy | focusbankers.com |
| American Healthcare Capital | American Healthcare Capital | Both | $5M-$200M | Home health, hospice, behavioral health, physician practices, urgent care | americanhealthcarecapital.com |
How to verify a Boston healthcare advisor's deal record
Ask for a closed deal list with healthcare-specific buyers and deal sizes from the last 24 months. A credible Boston healthcare advisor closes 10+ healthcare transactions per year with named buyers.
Check whether the advisor has sold to both PE platforms and Massachusetts hospital systems. Selling to Mass General Brigham is structurally different from selling to a PE rollup. Advisors who've done both know what each buyer demands in diligence.
Ask specifically whether the deal team understands Massachusetts Attorney General healthcare oversight requirements. MA AG review of healthcare consolidations is an additional regulatory step that can add 60-90 days to a Boston healthcare deal.
Use Ellty to organize your compliance records before buyer meetings. Read the Boston M&A advisors overview before narrowing to healthcare-specific firms.
Running a healthcare M&A process in Boston?
Organize your payor contracts and HIPAA records before buyers start diligence.
Start free 14-day trialWhat a Boston healthcare M&A deal looks like: 6 stages
Boston healthcare sell-side processes run five to eight months. Massachusetts AG oversight and CMS change-of-ownership (CHOW) notifications can extend timelines by two to four months.
| Stage | What happens | What you need ready | |
|---|---|---|---|
| Stage 1 | Preparation | Valuation, advisor selection, CIM drafted | 3 years financials, payor mix, compliance records |
| Stage 2 | Advisor engagement | Engagement letter signed, buyer list built | Engagement letter, NDA template, HIPAA summary |
| Stage 3 | Marketing | Teaser and CIM sent to PE and strategic buyers | Ellty data room with access staged by NDA tier |
| Stage 4 | LOI | Buyers submit bids, advisor shortlists top three | Updated financials, physician contracts, payor agreements |
| Stage 5 | Due diligence | Buyer reviews contracts, compliance, licenses, and HR | Full data room: licenses, payroll, compliance, payor contracts |
| Stage 6 | Close | Purchase agreement signed, CHOW filed, MA AG notified | Board approvals, CHOW notice, MA AG healthcare filing |
12 Boston healthcare M&A advisors in 2026
These firms are active in physician practices, home health, behavioral health, specialty pharmacy, health IT, and medical devices M&A in Boston in 2026.
1. Provident Healthcare Partners
Provident Healthcare Partners was established in 1998 and is headquartered in Boston, Massachusetts. Named Healthcare Investment Bank of the Year at the 13th Annual America's M&A Atlas Awards, Provident focuses exclusively on middle-market healthcare services M&A. In 2025, Provident advised Elder Care Homecare on its sale to Rallyday Partners (August 2025), CPS Infusion on its sale to Seven Hills Capital (September 2025), and Meperia on its sale to Diversis Capital (November 2025).
Recent Deals: Advised Elder Care Homecare on its sale to Rallyday Partners (August 2025). Advised CPS Infusion on its sale to Seven Hills Capital (September 2025). Advised Meperia on its acquisition by Diversis Capital (November 2025). Named Healthcare Investment Bank of the Year (2025).
LinkedIn: Provident Healthcare Partners on LinkedIn
Sector Focus: Physician practices, home health and hospice, specialty pharmacy, infusion, DME, behavioral health, dental
Deal Type: Both
Deal Size: $20M-$300M
Location: Boston, MA (headquarters, national coverage)
Website: providenthp.com
2. Outcome Capital
Outcome Capital is a Boston-based specialized life sciences and healthcare advisory firm established in 1998. They cover medical devices, diagnostics, life-science services, digital health, and biotech using a strategy-led execution model with senior MD engagement throughout. In February 2025, Outcome Capital advised RealizedCare on its sale to XRHealth. The firm expanded its medical device practice in 2025 by hiring Peter F. Meyer, PhD as Managing Director.
Recent Deals: Advised RealizedCare on its sale to XRHealth (February 2025). Expanded medical device and life-science services team with hire of Peter F. Meyer, PhD (2025).
LinkedIn: Outcome Capital on LinkedIn
Sector Focus: Medical devices, diagnostics, life-science services, digital health, biotech
Deal Type: Both
Deal Size: $10M-$150M
Location: Boston, MA (headquarters, national coverage)
Website: outcomecapital.com
3. Houlihan Lokey (Healthcare)
Houlihan Lokey's Healthcare Group achieved its most successful year in firm history in 2025, covering physician services, behavioral health, retail health, health IT, and medical products. Their Boston healthcare team provides mid-market healthcare service founders access to the largest buyer network in the market. Houlihan Lokey is the No. 1 global M&A advisor by deal volume for transactions under $1B.
Recent Deals: Active in physician services, behavioral health, and health IT M&A through 2025-2026. Healthcare group achieved record year in 2025 across M&A and capital advisory mandates.
LinkedIn: Houlihan Lokey on LinkedIn
Sector Focus: Physician services, behavioral health, retail health, health IT, medical products
Deal Type: Both
Deal Size: $50M-$5B+
Location: Boston, MA (office, global network)
Website: hl.com
4. Harris Williams (Healthcare and Life Sciences)
Harris Williams runs one of the most active healthcare M&A practices in the US, with dedicated teams covering health IT, medical products and devices, value-based care, payer and employer tech, and revenue cycle management. Their quarterly market reports track deal activity and buyer appetite across all healthcare sub-sectors. Harris Williams provides Boston healthcare founders access to every major PE platform running healthcare consolidations.
Recent Deals: Active in healthcare & life sciences M&A through 2025-2026 with quarterly market reports tracking medical products, health IT, and value-based care deal activity.
LinkedIn: Harris Williams on LinkedIn
Sector Focus: Healthcare & life sciences, health IT, medical products and devices, value-based care, revenue cycle management
Deal Type: Both
Deal Size: $50M-$2B+
Location: Boston, MA (East Coast coverage, national network)
Website: harriswilliams.com
Boston healthcare M&A data room
Share your payor contracts and HIPAA records securely with healthcare buyers.
Start free 14-day trial5. William Blair (Healthcare Services)
William Blair completed 17 signed or closed healthcare technology advisory deals in 2025, with a dedicated healthcare services team covering healthcare services, health IT, and medtech. Their Boston healthcare team provides access to both PE and strategic acquirers across the Northeast. William Blair advised Avalon Healthcare Solutions on its November 2025 recapitalization by WindRose Health Investors.
Recent Deals: Advised Avalon Healthcare Solutions on majority recapitalization by WindRose Health Investors (November 2025). Completed 17 healthcare technology M&A advisory deals in 2025.
LinkedIn: William Blair on LinkedIn
Sector Focus: Healthcare services, health IT, medical technology, pharma outsourcing
Deal Type: Both
Deal Size: $50M-$2B+
Location: Boston, MA (office, national network)
Website: williamblair.com
6. Lincoln International (Healthcare)
Lincoln International completed more than 45 healthcare transactions in an 18-month period through 2025 and has more than 30 dedicated healthcare officers worldwide. Their global network gives Boston healthcare founders cross-border buyer access for healthcare IT and medical technology businesses with international buyer interest.
Recent Deals: Completed 45+ healthcare transactions in the 18 months through 2025. Active in healthcare services and life sciences M&A through 2025-2026 with a rapidly expanding global team.
LinkedIn: Lincoln International on LinkedIn
Sector Focus: Healthcare services, life sciences, pharma outsourcing, medical products, health IT
Deal Type: Both
Deal Size: $50M-$1B+
Location: Boston, MA (East Coast coverage, Chicago headquarters)
Website: lincolninternational.com
7. Piper Sandler (Healthcare)
Piper Sandler covers healthcare services, health IT, pharma, biotech, and medical devices with a research-informed approach. Their Boston healthcare team is active across both PE-backed exits and strategic acquisitions in the healthcare sector. Piper Sandler's biotech and healthcare coverage gives Boston founders access to real-time buyer sentiment before going to market.
Recent Deals: Active in healthcare services, health IT, and pharma M&A through 2025-2026 with dedicated Boston coverage.
LinkedIn: Piper Sandler on LinkedIn
Sector Focus: Healthcare services, health IT, pharma, biotech, medical devices, diagnostics
Deal Type: Both
Deal Size: $50M-$2B+
Location: Boston, MA (East Coast office, national network)
Website: pipersandler.com
8. Jefferies (Healthcare)
Jefferies provides global buyer access for Boston healthcare founders targeting international strategic acquirers. Their large healthcare investment banking practice covers pharma, biotech, medical devices, and healthcare services. Jefferies is the right firm for Boston healthcare businesses where cross-border buyer access creates premium valuation optionality.
Recent Deals: Active in pharma, biotech, medical devices, and healthcare services M&A through 2025-2026 with global buyer access and East Coast office coverage.
LinkedIn: Jefferies on LinkedIn
Sector Focus: Pharma, biotech, medical devices, healthcare services, health IT
Deal Type: Both
Deal Size: $100M-$5B+
Location: Boston, MA (East Coast office, global network)
Website: jefferies.com
9. Raymond James (Healthcare)
Raymond James covers healthcare services, physician groups, home health, and specialty pharma with a research-informed advisory approach. Their Boston healthcare team serves mid-market healthcare founders at deal sizes from $25M to $1B with access to both PE and strategic buyers in the Northeast.
Recent Deals: Active in healthcare services and physician group M&A through 2025-2026 with East Coast coverage.
LinkedIn: Raymond James on LinkedIn
Sector Focus: Healthcare services, physician groups, home health, specialty pharma, long-term care
Deal Type: Both
Deal Size: $25M-$1B+
Location: Boston, MA (East Coast office, national network)
Website: raymondjames.com
10. M&A Healthcare Advisors
M&A Healthcare Advisors is a boutique advisory firm focused exclusively on the lower-middle market healthcare sector. In January 2025, MAHA advised Greater Boston Long Term Care Pharmacy on its sale to a strategic acquirer. Their healthcare-only focus and established buyer network make them the first call for Boston healthcare businesses below the minimum deal sizes of the larger national banks.
Recent Deals: Advised Greater Boston Long Term Care Pharmacy on its sale to a strategic acquirer (January 2025). Active in lower-middle market healthcare services M&A through 2025-2026.
LinkedIn: M&A Healthcare Advisors on LinkedIn
Sector Focus: Lower-middle market healthcare services, pharmacy, home health, physician practices, behavioral health
Deal Type: Sell-side
Deal Size: $5M-$100M
Location: National coverage with Boston market presence
Website: mahealthcareadvisors.com
11. FOCUS Investment Banking
FOCUS Investment Banking has closed 130+ healthcare transactions over the last decade, covering provider services, pharmacy, diagnostics, health technology, and animal health. Their healthcare practice gives Boston founders access to a comprehensive buyer network across both PE and strategic acquirers in the healthcare services sector.
Recent Deals: Closed 130+ healthcare transactions over the last decade. Active in healthcare services, provider services, pharmacy, and health IT M&A through 2025-2026.
LinkedIn: FOCUS Investment Banking on LinkedIn
Sector Focus: Healthcare services, provider services, pharmacy, diagnostics, health technology
Deal Type: Both
Deal Size: $5M-$250M
Location: National coverage with Northeast market presence
Website: focusbankers.com
12. American Healthcare Capital
American Healthcare Capital covers home health, hospice, behavioral health, physician practices, and urgent care with a dedicated healthcare buyer network. Their focus on lower-to-middle market healthcare services transactions fills the gap between healthcare boutiques and larger investment banks for Boston-area founder-owned healthcare businesses.
Recent Deals: Active in home health, hospice, behavioral health, and physician practice M&A through 2025-2026 with a dedicated healthcare buyer network.
LinkedIn: American Healthcare Capital on LinkedIn
Sector Focus: Home health, hospice, behavioral health, physician practices, urgent care, assisted living
Deal Type: Both
Deal Size: $5M-$200M
Location: National coverage with Northeast market presence
Website: americanhealthcarecapital.com
Massachusetts Attorney General healthcare oversight
Massachusetts has some of the most active healthcare market oversight in the US. The Massachusetts AG can review and delay healthcare consolidation transactions it deems anti-competitive.
Transactions involving hospital systems, large physician practice groups, or significant market share in a healthcare service category are most likely to attract MA AG scrutiny. Your advisor needs to factor this into deal timeline estimates.
Budget 60-90 additional days for MA AG notification review in any Boston healthcare deal involving a hospital system buyer or a large regional physician group. This is not optional - it's a regulatory requirement.
Use Ellty to organize your market concentration documentation before your advisor begins buyer outreach. Having organized market share data ready speeds up the regulatory review process.
HIPAA compliance and physician retention
HIPAA compliance documentation is the most common cause of Boston healthcare deal delays. Buyers who find BAA gaps or unsecured PHI after LOI reprice the deal or walk.
Physician retention post-close is the second most common deal issue in Boston healthcare M&A. Massachusetts physicians have strong employment protections - restrictive covenants are narrowly enforceable. Your advisor needs to understand Massachusetts physician employment law.
Build physician retention plans before starting the sale process. Buyers who find physicians without post-close employment agreements reprice for retention risk.
Use Ellty's secure sharing tools to coordinate with your attorney on physician retention documentation without leaving a paper trail that reaches physician staff prematurely.
How Ellty helps you run a Boston healthcare M&A process
Once you have your advisor, organize your compliance records and payor contracts. Boston healthcare buyers start diligence with HIPAA documentation and physician contract review.
- 1.Upload payor contracts, licenses, and compliance recordsAdd HIPAA compliance files and physician agreements before buyer outreach.
- 2.Stage access by NDA tier and buyer typeControl who sees patient data agreements and HIPAA compliance records.
- 3.Track buyer document activity in real timeSee which buyers review your payor contracts before management presentations.
Common questions about Boston healthcare M&A advisors
- Provident Healthcare Partners, established in 1998 in Boston, focuses exclusively on middle-market healthcare services M&A. They were named Healthcare Investment Bank of the Year in 2025 and closed four deals in 2025.
- Expect five to eight months. Massachusetts Attorney General healthcare oversight can add 60-90 days for transactions involving hospital systems or large physician groups in the state.
- The MA AG has broad oversight of healthcare consolidation and can review transactions for anti-competitive impact. Your advisor should assess MA AG notification requirements before starting the process.
- Massachusetts has strict limits on physician non-compete agreements. Your advisor and healthcare counsel should review physician employment agreements before the sale process starts to identify retention risk.
- Expect 3-5% for deals under $50M and 1-3% for deals above $100M, with minimum fees common for lower-middle market healthcare transactions.
- Before your first advisor meeting. Load payor contracts, HIPAA compliance records, and physician employment agreements so buyers don't find gaps in diligence that trigger repricing.
